No Carolina / NY / Florida
Ph: 561.316.3330

FDA COVID-19 Update for July 9, 2020

Summation

  • District Court in Florida granted a motion for default judgment and a permanent injunction against the Genesis II Church of Health and Healing, Jonathan Grenon, and Jordan Grenon for violating federal law by distributing their product, “Miracle Mineral Solution,”.
  • In prior warning statements, the FDA has urged consumers not to purchase or use MMS, explaining that drinking MMS is the same as drinking bleach and can cause dangerous side effects, including severe vomiting, diarrhea, and life-threatening low-blood pressure.
  •  In May, the federal judge entered a preliminary injunction against the Genesis II Church of Health and Healing and four individual defendants associated with the entity.

July 9, 2020

FDA today continued to take action in the ongoing response to the COVID-19 pandemic:

  • Today, a U.S. District Court in Florida granted a motion for default judgment and a permanent injunction against the Genesis II Church of Health and Healing, Jonathan Grenon, and Jordan Grenon for violating federal law by distributing their product, “Miracle Mineral Solution,” an industrial bleach that the defendants claim is a cure for COVID-19 and other serious diseases. The order issued today permanently prohibits the defendants from selling or distributing unapproved or misbranded products, such as Mineral Miracle Solution (MMS). In prior warning statements, the FDA has urged consumers not to purchase or use MMS, explaining that drinking MMS is the same as drinking bleach and can cause dangerous side effects, including severe vomiting, diarrhea, and life-threatening low-blood pressure. In May, the federal judge entered a preliminary injunction against the Genesis II Church of Health and Healing and four individual defendants associated with the entity.
  • Testing updates:
    • To date, the FDA has currently authorized 171 tests under EUAs; these include 142 molecular tests, 27 antibody tests, and 2 antigen tests.

Other FDA News of Interest

Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B

Intuity Medical, Inc., a medical technology company committed to making it easier to live with diabetes, announced today that its POGO Automatic® Blood Glucose...

XT-Thrive® Drug Master File (DMF) Accepted by the FDA | Reports X-Therma

X-Therma notes this DMF covers the Chemistry, Manufacturing and Controls (CMC) for this key chemistry innovation, which enables non-toxic cryopreservation for life-saving regenerative medicines.

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte™ Image Guided Crossing and Re-Entry Catheter System

Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System. The company looks forward to bringing this revolutionary technology to clinicians, and patients in need.

spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy